25 XP   0   0   10

Sino Biopharmaceutical Ltd
Buy, Hold or Sell?

Let's analyse Sino Biopharmaceutical Ltd together

PenkeI guess you are interested in Sino Biopharmaceutical Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sino Biopharmaceutical Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sino Biopharmaceutical Ltd

I send you an email if I find something interesting about Sino Biopharmaceutical Ltd.

Quick analysis of Sino Biopharmaceutical Ltd (30 sec.)










What can you expect buying and holding a share of Sino Biopharmaceutical Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
67.6%

What is your share worth?

Current worth
HK$1.72
Expected worth in 1 year
HK$1.71
How sure are you?
73.0%

+ What do you gain per year?

Total Gains per Share
HK$-0.01
Return On Investment
-0.4%

For what price can you sell your share?

Current Price per Share
HK$2.88
Expected price per share
HK$2.29 - HK$3.46
How sure are you?
50%

1. Valuation of Sino Biopharmaceutical Ltd (5 min.)




Live pricePrice per Share (EOD)

HK$2.88

2. Growth of Sino Biopharmaceutical Ltd (5 min.)




Is Sino Biopharmaceutical Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$4.1b$3.9b$149.2m3.6%

How much money is Sino Biopharmaceutical Ltd making?

Current yearPrevious yearGrowGrow %
Making money$81.9m$667.8m-$585.8m-715.2%
Net Profit Margin3.2%16.8%--

How much money comes from the company's main activities?

3. Financial Health of Sino Biopharmaceutical Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#18 / 1007

Most Revenue
#5 / 1007

Most Profit
#11 / 1007

Most Efficient
#117 / 1007

What can you expect buying and holding a share of Sino Biopharmaceutical Ltd? (5 min.)

Welcome investor! Sino Biopharmaceutical Ltd's management wants to use your money to grow the business. In return you get a share of Sino Biopharmaceutical Ltd.

What can you expect buying and holding a share of Sino Biopharmaceutical Ltd?

First you should know what it really means to hold a share of Sino Biopharmaceutical Ltd. And how you can make/lose money.

Speculation

The Price per Share of Sino Biopharmaceutical Ltd is HK$2.88. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sino Biopharmaceutical Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sino Biopharmaceutical Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$1.72. Based on the TTM, the Book Value Change Per Share is HK$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sino Biopharmaceutical Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.000.1%0.000.1%0.010.5%0.010.4%0.010.2%
Usd Book Value Change Per Share0.000.1%0.000.0%0.010.4%0.000.1%0.000.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.1%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.1%0.000.0%0.010.4%0.000.1%0.010.2%
Usd Price Per Share0.44-0.51-0.70-1.13-1.92-
Price to Earnings Ratio25.48-30.01-16.66-58.37-171.01-
Price-to-Total Gains Ratio259.10-39.95--680.78-50.85-733.57-
Price to Book Ratio1.98-2.34-3.36-4.71-24.34-
Price-to-Total Gains Ratio259.10-39.95--680.78-50.85-733.57-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.36864
Number of shares2712
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (2712 shares)-1.078.65
Gains per Year (2712 shares)-4.2834.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-4-14102425
20-9-18214860
30-13-22317395
40-17-264297130
50-21-3052121165
60-26-3462145200
70-30-3873169235
80-34-4283194270
90-39-4694218305
100-43-50104242340

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.00.00.0100.0%37.00.00.0100.0%57.00.00.0100.0%
Book Value Change Per Share1.01.02.025.0%3.05.04.025.0%10.05.04.052.6%24.09.04.064.9%39.014.04.068.4%
Dividend per Share0.00.04.00.0%4.00.08.033.3%7.00.012.036.8%25.00.012.067.6%45.00.012.078.9%
Total Gains per Share1.01.02.025.0%4.05.03.033.3%11.05.03.057.9%27.07.03.073.0%44.010.03.077.2%

Fundamentals of Sino Biopharmaceutical Ltd

About Sino Biopharmaceutical Ltd

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection. It also provides surgery/analgesia medicines comprising Debaian cataplasms and Gaisanchun soft capsules; and cardio-cerebral vascular medicines, including Yilunping and Kaina tablets. In addition, the company is involved in the long term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

Fundamental data was last updated by Penke on 2024-04-15 18:54:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.

1.1. Profitability of Sino Biopharmaceutical Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sino Biopharmaceutical Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Sino Biopharmaceutical Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 8.2% means that $0.08 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sino Biopharmaceutical Ltd:

  • The MRQ is 8.2%. The company is making a profit. +1
  • The TTM is 3.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ8.2%TTM3.2%+5.0%
TTM3.2%YOY16.8%-13.6%
TTM3.2%5Y20.5%-17.3%
5Y20.5%10Y16.6%+4.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.2%-207.2%+215.4%
TTM3.2%-216.8%+220.0%
YOY16.8%-282.4%+299.2%
5Y20.5%-426.4%+446.9%
10Y16.6%-589.3%+605.9%
1.1.2. Return on Assets

Shows how efficient Sino Biopharmaceutical Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sino Biopharmaceutical Ltd to the Biotechnology industry mean.
  • 1.8% Return on Assets means that Sino Biopharmaceutical Ltd generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sino Biopharmaceutical Ltd:

  • The MRQ is 1.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.9%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.8%TTM0.9%+0.9%
TTM0.9%YOY8.0%-7.1%
TTM0.9%5Y4.0%-3.0%
5Y4.0%10Y3.2%+0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8%-13.0%+14.8%
TTM0.9%-12.5%+13.4%
YOY8.0%-11.2%+19.2%
5Y4.0%-13.6%+17.6%
10Y3.2%-15.2%+18.4%
1.1.3. Return on Equity

Shows how efficient Sino Biopharmaceutical Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sino Biopharmaceutical Ltd to the Biotechnology industry mean.
  • 3.9% Return on Equity means Sino Biopharmaceutical Ltd generated $0.04 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sino Biopharmaceutical Ltd:

  • The MRQ is 3.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.9%TTM2.0%+1.9%
TTM2.0%YOY16.6%-14.6%
TTM2.0%5Y8.2%-6.2%
5Y8.2%10Y6.5%+1.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9%-16.6%+20.5%
TTM2.0%-15.7%+17.7%
YOY16.6%-14.2%+30.8%
5Y8.2%-18.9%+27.1%
10Y6.5%-19.9%+26.4%

1.2. Operating Efficiency of Sino Biopharmaceutical Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sino Biopharmaceutical Ltd is operating .

  • Measures how much profit Sino Biopharmaceutical Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sino Biopharmaceutical Ltd to the Biotechnology industry mean.
  • An Operating Margin of 10.2% means the company generated $0.10  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sino Biopharmaceutical Ltd:

  • The MRQ is 10.2%. The company is operating less efficient.
  • The TTM is 2.6%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ10.2%TTM2.6%+7.7%
TTM2.6%YOY3.1%-0.6%
TTM2.6%5Y19.2%-16.6%
5Y19.2%10Y20.1%-0.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.2%-285.4%+295.6%
TTM2.6%-226.2%+228.8%
YOY3.1%-288.4%+291.5%
5Y19.2%-469.6%+488.8%
10Y20.1%-599.3%+619.4%
1.2.2. Operating Ratio

Measures how efficient Sino Biopharmaceutical Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.21 means that the operating costs are $0.21 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Sino Biopharmaceutical Ltd:

  • The MRQ is 0.213. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.105. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.213TTM0.105+0.108
TTM0.105YOY0.098+0.007
TTM0.1055Y0.459-0.354
5Y0.45910Y0.627-0.168
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2133.231-3.018
TTM0.1053.303-3.198
YOY0.0983.763-3.665
5Y0.4595.586-5.127
10Y0.6277.464-6.837

1.3. Liquidity of Sino Biopharmaceutical Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sino Biopharmaceutical Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.00 means the company has $1.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Sino Biopharmaceutical Ltd:

  • The MRQ is 1.004. The company is just able to pay all its short-term debts.
  • The TTM is 0.824. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ1.004TTM0.824+0.180
TTM0.824YOY1.540-0.717
TTM0.8245Y1.924-1.100
5Y1.92410Y1.990-0.066
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0043.855-2.851
TTM0.8244.160-3.336
YOY1.5405.323-3.783
5Y1.9246.122-4.198
10Y1.9906.480-4.490
1.3.2. Quick Ratio

Measures if Sino Biopharmaceutical Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sino Biopharmaceutical Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 1.31 means the company can pay off $1.31 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sino Biopharmaceutical Ltd:

  • The MRQ is 1.312. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 0.765. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.312TTM0.765+0.547
TTM0.765YOY1.058-0.293
TTM0.7655Y1.482-0.717
5Y1.48210Y1.050+0.432
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3123.506-2.194
TTM0.7654.001-3.236
YOY1.0585.390-4.332
5Y1.4826.127-4.645
10Y1.0506.488-5.438

1.4. Solvency of Sino Biopharmaceutical Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sino Biopharmaceutical Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sino Biopharmaceutical Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.54 means that Sino Biopharmaceutical Ltd assets are financed with 54.3% credit (debt) and the remaining percentage (100% - 54.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sino Biopharmaceutical Ltd:

  • The MRQ is 0.543. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.537. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.543TTM0.537+0.006
TTM0.537YOY0.524+0.013
TTM0.5375Y0.453+0.084
5Y0.45310Y0.419+0.035
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5430.344+0.199
TTM0.5370.339+0.198
YOY0.5240.275+0.249
5Y0.4530.368+0.085
10Y0.4190.389+0.030
1.4.2. Debt to Equity Ratio

Measures if Sino Biopharmaceutical Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sino Biopharmaceutical Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 118.9% means that company has $1.19 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sino Biopharmaceutical Ltd:

  • The MRQ is 1.189. The company is able to pay all its debts with equity. +1
  • The TTM is 1.161. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.189TTM1.161+0.028
TTM1.161YOY1.108+0.053
TTM1.1615Y0.981+0.180
5Y0.98110Y0.871+0.111
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1890.390+0.799
TTM1.1610.408+0.753
YOY1.1080.341+0.767
5Y0.9810.438+0.543
10Y0.8710.469+0.402

2. Market Valuation of Sino Biopharmaceutical Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Sino Biopharmaceutical Ltd generates.

  • Above 15 is considered overpriced but always compare Sino Biopharmaceutical Ltd to the Biotechnology industry mean.
  • A PE ratio of 25.48 means the investor is paying $25.48 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sino Biopharmaceutical Ltd:

  • The EOD is 21.517. Based on the earnings, the company is fair priced.
  • The MRQ is 25.477. Based on the earnings, the company is overpriced. -1
  • The TTM is 30.011. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD21.517MRQ25.477-3.960
MRQ25.477TTM30.011-4.534
TTM30.011YOY16.663+13.348
TTM30.0115Y58.373-28.362
5Y58.37310Y171.008-112.636
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD21.517-2.351+23.868
MRQ25.477-2.599+28.076
TTM30.011-2.762+32.773
YOY16.663-4.025+20.688
5Y58.373-6.305+64.678
10Y171.008-6.538+177.546
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sino Biopharmaceutical Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y7.818-7.818
5Y7.81810Y142.916-135.098
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.306+3.306
TTM--3.607+3.607
YOY--5.524+5.524
5Y7.818-8.299+16.117
10Y142.916-8.910+151.826
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sino Biopharmaceutical Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.98 means the investor is paying $1.98 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Sino Biopharmaceutical Ltd:

  • The EOD is 1.675. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.983. Based on the equity, the company is underpriced. +1
  • The TTM is 2.343. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.675MRQ1.983-0.308
MRQ1.983TTM2.343-0.360
TTM2.343YOY3.359-1.016
TTM2.3435Y4.714-2.371
5Y4.71410Y24.341-19.628
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.6752.019-0.344
MRQ1.9832.116-0.133
TTM2.3432.099+0.244
YOY3.3592.873+0.486
5Y4.7143.556+1.158
10Y24.3413.946+20.395
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sino Biopharmaceutical Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.013-0.003+123%0.082-84%0.017-24%0.039-66%
Book Value Per Share--1.7191.716+0%1.651+4%1.832-6%1.220+41%
Current Ratio--1.0040.824+22%1.540-35%1.924-48%1.990-50%
Debt To Asset Ratio--0.5430.537+1%0.524+4%0.453+20%0.419+30%
Debt To Equity Ratio--1.1891.161+2%1.108+7%0.981+21%0.871+37%
Dividend Per Share----0%0.013-100%0.007-100%0.007-100%
Eps--0.0330.0330%0.107-69%0.088-62%0.055-39%
Gross Profit Margin--1.0000.750+33%1.0000%-0.404+140%-1.388+239%
Market Cap54147453419.520-18%64139430754.30075553563356.470-15%102586650157.350-37%166952639042.905-62%283044731919.218-77%
Net Profit Margin--0.0820.032+157%0.168-51%0.205-60%0.166-50%
Operating Margin--0.1020.026+300%0.031+229%0.192-47%0.201-49%
Operating Ratio--0.2130.105+102%0.098+117%0.459-54%0.627-66%
Pb Ratio1.675-18%1.9832.343-15%3.359-41%4.714-58%24.341-92%
Pe Ratio21.517-18%25.47730.011-15%16.663+53%58.373-56%171.008-85%
Price Per Share2.880-18%3.4104.018-15%5.445-37%8.851-61%15.011-77%
Price To Free Cash Flow Ratio----0%-0%7.818-100%142.916-100%
Price To Total Gains Ratio218.827-18%259.09739.947+549%-680.777+363%50.847+410%733.566-65%
Quick Ratio--1.3120.765+72%1.058+24%1.482-11%1.050+25%
Return On Assets--0.0180.009+94%0.080-78%0.040-55%0.032-45%
Return On Equity--0.0390.020+96%0.166-77%0.082-53%0.065-40%
Total Gains Per Share--0.013-0.003+123%0.095-86%0.025-47%0.046-71%
Usd Book Value--4139194470.2084130234746.112+0%3980980428.256+4%4422033510.020-6%2944214761.546+41%
Usd Book Value Change Per Share--0.0020.000+123%0.010-84%0.002-24%0.005-66%
Usd Book Value Per Share--0.2200.220+0%0.211+4%0.235-6%0.156+41%
Usd Dividend Per Share----0%0.002-100%0.001-100%0.001-100%
Usd Eps--0.0040.0040%0.014-69%0.011-62%0.007-39%
Usd Free Cash Flow----0%-0%19562882.725-100%40611382.526-100%
Usd Market Cap6930874037.699-18%8209847136.5509670856109.628-15%13131091220.141-37%21369937797.492-62%36229725685.660-77%
Usd Price Per Share0.369-18%0.4360.514-15%0.697-37%1.133-61%1.921-77%
Usd Profit--161124352.00081919692.595+97%667812035.755-76%310877800.495-48%184524695.636-13%
Usd Revenue--1955460736.000923638752.000+112%1345763008.000+45%980582777.263+99%700972797.147+179%
Usd Total Gains Per Share--0.0020.000+123%0.012-86%0.003-47%0.006-71%
 EOD+3 -4MRQTTM+20 -8YOY+9 -205Y+8 -2410Y+11 -21

3.2. Fundamental Score

Let's check the fundamental score of Sino Biopharmaceutical Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1521.517
Price to Book Ratio (EOD)Between0-11.675
Net Profit Margin (MRQ)Greater than00.082
Operating Margin (MRQ)Greater than00.102
Quick Ratio (MRQ)Greater than11.312
Current Ratio (MRQ)Greater than11.004
Debt to Asset Ratio (MRQ)Less than10.543
Debt to Equity Ratio (MRQ)Less than11.189
Return on Equity (MRQ)Greater than0.150.039
Return on Assets (MRQ)Greater than0.050.018
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Sino Biopharmaceutical Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.021
Ma 20Greater thanMa 502.697
Ma 50Greater thanMa 1002.939
Ma 100Greater thanMa 2003.045
OpenGreater thanClose2.720
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets65,640,887
Total Liabilities35,651,592
Total Stockholder Equity29,989,295
 As reported
Total Liabilities 35,651,592
Total Stockholder Equity+ 29,989,295
Total Assets = 65,640,887

Assets

Total Assets65,640,887
Total Current Assets26,977,269
Long-term Assets38,663,618
Total Current Assets
Cash And Cash Equivalents 2,821,838
Short-term Investments 12,382,436
Net Receivables 7,188,856
Inventory 2,018,498
Total Current Assets  (as reported)26,977,269
Total Current Assets  (calculated)24,411,628
+/- 2,565,641
Long-term Assets
Property Plant Equipment 9,584,248
Goodwill 812,083
Intangible Assets 2,129,608
Other Assets 1,874,340
Long-term Assets  (as reported)38,663,618
Long-term Assets  (calculated)14,400,279
+/- 24,263,339

Liabilities & Shareholders' Equity

Total Current Liabilities26,865,415
Long-term Liabilities2,316,667
Total Stockholder Equity29,989,295
Total Current Liabilities
Short Long Term Debt 10,484,951
Accounts payable 2,167,010
Other Current Liabilities 14,175,665
Total Current Liabilities  (as reported)26,865,415
Total Current Liabilities  (calculated)26,827,626
+/- 37,789
Long-term Liabilities
Long term Debt Total 1,031,340
Other Liabilities 1,285,342
Long-term Liabilities  (as reported)2,316,667
Long-term Liabilities  (calculated)2,316,682
+/- 15
Total Stockholder Equity
Common Stock414,615
Retained Earnings 28,640,956
Capital Surplus 12,420,311
Other Stockholders Equity -9,882,505
Total Stockholder Equity (as reported)29,989,295
Total Stockholder Equity (calculated)31,593,377
+/- 1,604,082
Other
Capital Stock414,615
Cash And Equivalents472,126
Cash and Short Term Investments 15,676,400
Common Stock Shares Outstanding 18,809,217
Liabilities and Stockholders Equity 65,640,887
Net Invested Capital 41,176,325
Net Tangible Assets 27,047,604
Net Working Capital 111,854
Property Plant and Equipment Gross 9,584,248



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302011-12-312011-09-302011-06-302011-03-312010-12-312010-06-302009-12-312009-06-302008-12-312008-06-302007-12-312007-06-302006-12-312006-06-302005-12-312005-06-302004-12-312004-06-30
> Total Assets 
858,793
950,535
1,114,416
2,140,222
2,225,361
2,215,110
2,368,976
2,595,664
3,132,098
3,267,380
3,552,202
3,316,055
4,653,913
5,620,836
4,935,760
5,324,229
5,272,215
5,095,122
5,913,399
6,442,467
6,292,710
6,871,278
7,213,525
7,659,786
7,789,741
8,824,058
10,421,822
10,780,696
11,326,059
12,370,020
13,465,039
14,351,397
13,802,211
15,120,167
15,690,686
17,708,420
18,391,162
19,902,169
19,606,370
20,583,228
20,935,339
34,498,302
34,985,598
37,293,487
49,780,208
51,439,141
53,471,187
53,774,095
58,299,251
66,640,032
68,348,340
66,200,806
47,210,438
49,152,789
56,206,729
0
60,543,337
0
64,934,460
0
64,064,284
0
65,640,887
65,640,887064,064,284064,934,460060,543,337056,206,72949,152,78947,210,43866,200,80668,348,34066,640,03258,299,25153,774,09553,471,18751,439,14149,780,20837,293,48734,985,59834,498,30220,935,33920,583,22819,606,37019,902,16918,391,16217,708,42015,690,68615,120,16713,802,21114,351,39713,465,03912,370,02011,326,05910,780,69610,421,8228,824,0587,789,7417,659,7867,213,5256,871,2786,292,7106,442,4675,913,3995,095,1225,272,2155,324,2294,935,7605,620,8364,653,9133,316,0553,552,2023,267,3803,132,0982,595,6642,368,9762,215,1102,225,3612,140,2221,114,416950,535858,793
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
2,324,236
3,512,201
0
3,548,144
3,895,787
3,831,056
3,133,056
3,846,463
4,372,569
4,123,650
4,313,944
4,466,097
4,759,338
4,553,173
5,448,955
6,747,906
7,251,446
6,541,479
7,030,129
8,039,834
9,125,713
8,319,980
9,545,616
9,935,124
11,805,718
12,725,461
14,241,146
13,231,455
13,965,312
13,780,119
16,717,415
16,880,121
18,572,025
18,538,125
20,175,292
21,865,171
21,856,565
24,913,095
32,948,008
34,401,088
30,399,034
22,794,203
21,790,612
23,813,318
23,503,178
23,503,178
25,197,761
25,197,761
0
25,934,905
26,977,269
26,977,269
26,977,26926,977,26925,934,905025,197,76125,197,76123,503,17823,503,17823,813,31821,790,61222,794,20330,399,03434,401,08832,948,00824,913,09521,856,56521,865,17120,175,29218,538,12518,572,02516,880,12116,717,41513,780,11913,965,31213,231,45514,241,14612,725,46111,805,7189,935,1249,545,6168,319,9809,125,7138,039,8347,030,1296,541,4797,251,4466,747,9065,448,9554,553,1734,759,3384,466,0974,313,9444,123,6504,372,5693,846,4633,133,0563,831,0563,895,7873,548,14403,512,2012,324,23600000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
1,608,856
2,352,584
0
1,759,215
1,820,434
1,921,869
1,707,805
2,038,622
2,339,557
2,319,109
2,288,852
2,143,125
2,326,178
2,329,642
2,782,596
3,855,550
3,843,428
3,573,059
3,837,004
2,882,654
3,571,632
2,270,188
2,339,336
3,253,282
3,571,029
3,763,799
4,039,670
3,859,639
4,926,930
4,188,140
5,044,578
5,539,552
6,300,784
6,676,042
6,190,308
7,181,548
6,135,649
11,911,210
16,118,465
17,090,761
6,834,122
11,259,084
1,843,724
2,452,050
0
10,568,812
0
4,212,456
0
6,413,982
0
2,821,838
2,821,83806,413,98204,212,456010,568,81202,452,0501,843,72411,259,0846,834,12217,090,76116,118,46511,911,2106,135,6497,181,5486,190,3086,676,0426,300,7845,539,5525,044,5784,188,1404,926,9303,859,6394,039,6703,763,7993,571,0293,253,2822,339,3362,270,1883,571,6322,882,6543,837,0043,573,0593,843,4283,855,5502,782,5962,329,6422,326,1782,143,1252,288,8522,319,1092,339,5572,038,6221,707,8051,921,8691,820,4341,759,21502,352,5841,608,85600000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
47,454
179,338
0
399,835
398,529
366,834
106,131
78,569
84,145
96,204
110,740
106,616
123,590
108,367
144,070
140,111
454,682
423,546
432,905
1,103,850
949,893
2,412,076
1,925,914
1,857,812
3,005,037
2,529,521
3,332,958
3,529,330
3,391,729
3,591,152
3,857,484
3,454,240
4,286,830
2,000,685
2,808,053
2,898,221
3,309,982
1,576,240
1,761,824
1,982,591
2,429,493
4,216,731
3,004,504
2,415,020
0
4,655,739
0
9,609,386
0
8,266,858
0
12,382,436
12,382,43608,266,85809,609,38604,655,73902,415,0203,004,5044,216,7312,429,4931,982,5911,761,8241,576,2403,309,9822,898,2212,808,0532,000,6854,286,8303,454,2403,857,4843,591,1523,391,7293,529,3303,332,9582,529,5213,005,0371,857,8121,925,9142,412,076949,8931,103,850432,905423,546454,682140,111144,070108,367123,590106,616110,74096,20484,14578,569106,131366,834398,529399,8350179,33847,45400000000000
       Net Receivables 
168,605
118,340
162,308
112,988
137,951
131,714
163,378
201,771
328,336
383,282
486,324
517,260
662,811
793,480
0
1,270,265
0
1,092,093
1,042,934
0
1,375,211
0
1,615,859
0
1,719,032
0
2,006,856
0
2,124,054
0
2,334,913
0
2,083,080
0
2,557,873
0
3,451,211
0
2,399,646
0
2,744,791
0
3,243,388
0
3,865,169
3,093,103
3,523,360
3,791,493
3,342,972
2,758,033
4,473,882
3,855,532
3,039,613
3,367,767
5,174,742
5,537,259
5,537,259
5,354,760
5,354,760
0
4,638,396
7,188,856
7,188,856
7,188,8567,188,8564,638,39605,354,7605,354,7605,537,2595,537,2595,174,7423,367,7673,039,6133,855,5324,473,8822,758,0333,342,9723,791,4933,523,3603,093,1033,865,16903,243,38802,744,79102,399,64603,451,21102,557,87302,083,08002,334,91302,124,05402,006,85601,719,03201,615,85901,375,21101,042,9341,092,09301,270,2650793,480662,811517,260486,324383,282328,336201,771163,378131,714137,951112,988162,308118,340168,605
       Other Current Assets 
1,752
19,190
328,681
1,565
0
3,234
33,469
26,238
161,543
15,248
124,423
29,990
182,217
37,363
0
336,460
0
86,072
323,523
0
155,541
0
550,580
0
182,491
0
645,333
0
156,843
0
1,895,637
0
116,545
0
2,135,646
0
190,450
0
2,568,941
0
212,213
0
3,441,735
0
37,116
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000037,11603,441,7350212,21302,568,9410190,45002,135,6460116,54501,895,6370156,8430645,3330182,4910550,5800155,5410323,52386,0720336,460037,363182,21729,990124,42315,248161,54326,23833,4693,23401,565328,68119,1901,752
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31,263,849
31,606,016
31,917,530
33,386,156
33,692,024
33,947,252
35,801,772
24,416,235
0
32,393,411
0
37,040,159
0
39,736,699
0
38,129,379
0
38,663,618
38,663,618038,129,379039,736,699037,040,159032,393,411024,416,23535,801,77233,947,25233,692,02433,386,15631,917,53031,606,01631,263,849000000000000000000000000000000000000000000000
       Property Plant Equipment 
248,814
287,250
188,497
198,662
201,074
237,955
243,802
339,400
444,506
584,102
672,781
895,289
1,024,885
1,242,999
1,086,529
1,360,241
1,143,863
1,687,824
1,715,937
1,463,893
1,927,746
1,494,293
1,765,342
1,590,563
2,107,111
1,844,692
2,120,202
1,971,275
2,340,180
2,188,606
2,415,424
2,284,250
2,656,187
2,502,781
2,696,700
2,655,254
2,999,626
3,164,924
2,866,296
3,872,494
3,483,253
5,717,068
4,862,571
6,265,794
5,804,369
5,950,155
6,170,665
6,531,548
8,207,206
8,335,472
8,572,732
8,655,305
8,392,204
8,762,276
8,726,665
8,516,062
8,516,062
8,772,476
8,772,476
0
9,251,183
9,584,248
9,584,248
9,584,2489,584,2489,251,18308,772,4768,772,4768,516,0628,516,0628,726,6658,762,2768,392,2048,655,3058,572,7328,335,4728,207,2066,531,5486,170,6655,950,1555,804,3696,265,7944,862,5715,717,0683,483,2533,872,4942,866,2963,164,9242,999,6262,655,2542,696,7002,502,7812,656,1872,284,2502,415,4242,188,6062,340,1801,971,2752,120,2021,844,6922,107,1111,590,5631,765,3421,494,2931,927,7461,463,8931,715,9371,687,8241,143,8631,360,2411,086,5291,242,9991,024,885895,289672,781584,102444,506339,400243,802237,955201,074198,662188,497287,250248,814
       Goodwill 
2,653
41,900
41,433
41,948
41,973
42,031
42,101
44,322
44,481
47,684
47,681
41,983
41,729
67,308
56,814
56,016
55,432
63,654
64,484
63,745
63,349
31,075
40,537
40,345
45,386
46,386
46,547
50,025
88,640
88,740
101,636
90,963
92,705
92,336
94,639
95,140
98,956
99,384
99,384
99,384
88,926
9,908,641
9,908,639
9,908,639
13,896,976
13,896,976
13,896,976
13,896,976
13,896,976
13,896,976
13,896,976
13,896,976
88,926
890,829
906,031
0
647,930
0
642,552
0
662,611
0
812,083
812,0830662,6110642,5520647,9300906,031890,82988,92613,896,97613,896,97613,896,97613,896,97613,896,97613,896,97613,896,97613,896,9769,908,6399,908,6399,908,64188,92699,38499,38499,38498,95695,14094,63992,33692,70590,963101,63688,74088,64050,02546,54746,38645,38640,34540,53731,07563,34963,74564,48463,65455,43256,01656,81467,30841,72941,98347,68147,68444,48144,32242,10142,03141,97341,94841,43341,9002,653
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,576,172
0
1,708,430
0
1,778,714
0
1,184,452
0
1,069,609
0
1,211,926
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001,211,92601,069,60901,184,45201,778,71401,708,43001,576,172000000000000000000000000000000000000
       Intangible Assets 
11,024
50,432
41,902
45,750
50,900
61,374
81,199
103,408
106,732
135,056
169,814
48,455
51,010
216,921
55,562
54,855
56,008
61,287
63,513
63,677
68,819
64,127
67,193
70,339
68,575
66,006
70,788
76,194
129,728
135,989
140,371
152,725
166,561
173,685
181,412
187,364
182,473
177,892
177,243
175,418
219,249
233,629
243,141
254,788
8,349,174
8,148,349
8,045,862
7,879,540
7,703,642
7,504,229
7,435,984
7,302,053
924,710
848,788
915,743
0
1,064,016
0
1,214,069
0
1,251,839
0
2,129,608
2,129,60801,251,83901,214,06901,064,0160915,743848,788924,7107,302,0537,435,9847,504,2297,703,6427,879,5408,045,8628,148,3498,349,174254,788243,141233,629219,249175,418177,243177,892182,473187,364181,412173,685166,561152,725140,371135,989129,72876,19470,78866,00668,57570,33967,19364,12768,81963,67763,51361,28756,00854,85555,562216,92151,01048,455169,814135,056106,732103,40881,19961,37450,90045,75041,90250,43211,024
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
81,646
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31,606,016
0
33,386,156
0
0
0
0
0
0
0
0
0
0
0
508,261
0
651,783
651,7830508,2610000000000033,386,156031,606,01600000000000000000000000000081,646000000000000000000
> Total Liabilities 
356,792
282,745
446,272
164,978
292,251
183,611
343,144
375,361
737,866
615,446
819,825
650,104
1,001,006
1,319,288
1,238,447
1,752,306
1,671,654
1,229,476
1,873,632
2,077,656
1,634,912
1,984,241
2,375,291
2,430,011
2,144,105
2,896,607
4,501,361
4,299,197
4,274,593
4,981,800
6,008,190
6,207,898
5,057,416
5,980,809
6,561,158
7,851,751
7,701,900
8,724,409
8,694,361
8,689,788
8,324,290
9,912,761
10,688,842
11,885,073
12,230,684
13,475,611
14,659,822
14,639,706
18,014,683
25,557,070
26,845,487
34,528,437
24,790,880
30,487,168
31,631,106
0
30,252,221
0
34,720,305
0
34,317,249
0
35,651,592
35,651,592034,317,249034,720,305030,252,221031,631,10630,487,16824,790,88034,528,43726,845,48725,557,07018,014,68314,639,70614,659,82213,475,61112,230,68411,885,07310,688,8429,912,7618,324,2908,689,7888,694,3618,724,4097,701,9007,851,7516,561,1585,980,8095,057,4166,207,8986,008,1904,981,8004,274,5934,299,1974,501,3612,896,6072,144,1052,430,0112,375,2911,984,2411,634,9122,077,6561,873,6321,229,4761,671,6541,752,3061,238,4471,319,2881,001,006650,104819,825615,446737,866375,361343,144183,611292,251164,978446,272282,745356,792
   > Total Current Liabilities 
278,792
237,807
444,001
162,574
289,847
170,907
330,213
323,600
681,649
579,619
771,005
604,872
891,596
1,095,560
1,029,816
1,529,970
1,480,959
1,109,200
1,738,201
1,937,220
1,514,986
1,864,374
2,270,779
2,302,014
2,015,928
2,566,513
3,324,202
3,119,003
3,087,629
3,507,575
4,537,449
4,674,846
4,625,729
5,496,819
6,090,227
6,647,841
5,653,228
6,861,006
6,902,165
6,190,578
5,688,451
6,998,838
7,689,554
10,503,416
9,668,621
10,911,291
10,142,750
10,085,603
8,123,025
9,800,522
10,534,902
9,943,931
10,943,539
10,358,462
11,485,492
15,345,019
15,345,019
16,265,507
16,265,507
0
20,150,677
26,865,415
26,865,415
26,865,41526,865,41520,150,677016,265,50716,265,50715,345,01915,345,01911,485,49210,358,46210,943,5399,943,93110,534,9029,800,5228,123,02510,085,60310,142,75010,911,2919,668,62110,503,4167,689,5546,998,8385,688,4516,190,5786,902,1656,861,0065,653,2286,647,8416,090,2275,496,8194,625,7294,674,8464,537,4493,507,5753,087,6293,119,0033,324,2022,566,5132,015,9282,302,0142,270,7791,864,3741,514,9861,937,2201,738,2011,109,2001,480,9591,529,9701,029,8161,095,560891,596604,872771,005579,619681,649323,600330,213170,907289,847162,574444,001237,807278,792
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
1,000
10,044
0
90,197
44,033
74,160
40,944
141,740
168,494
17,027
12,012
20,086
34,059
57,944
76,617
60,148
47,782
347,993
176,171
170,958
84,449
1,189,071
1,174,559
1,203,578
1,241,692
1,368,719
1,202,752
998,823
739,602
741,307
953,256
1,079,501
3,014,477
2,905,575
2,812,341
787,199
795,745
666,749
86,684
307,575
0
1,552,825
0
0
0
0
0
0
0
0
0
0
00000000001,552,8250307,57586,684666,749795,745787,1992,812,3412,905,5753,014,4771,079,501953,256741,307739,602998,8231,202,7521,368,7191,241,6921,203,5781,174,5591,189,07184,449170,958176,171347,99347,78260,14876,61757,94434,05920,08612,01217,027168,494141,74040,94474,16044,03390,197010,0441,00000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,402,670
0
2,631,350
0
13,217
0
1,079,501
0
48,107
2,812,341
787,199
795,745
666,749
86,684
307,575
305,870
1,552,825
0
1,824,681
0
6,520,565
0
4,068,753
0
9,663,410
0
10,484,951
10,484,95109,663,41004,068,75306,520,56501,824,68101,552,825305,870307,57586,684666,749795,745787,1992,812,34148,10701,079,501013,21702,631,35003,402,670000000000000000000000000000000000000
       Accounts payable 
32,999
17,236
21,151
20,559
38,164
23,868
29,194
40,720
72,913
79,919
112,800
125,839
199,955
162,360
0
244,836
0
238,533
276,599
0
306,987
0
463,993
0
476,126
0
529,070
0
809,200
0
1,430,431
0
767,592
0
807,212
0
922,801
0
1,165,229
0
928,607
0
841,482
0
1,832,166
2,257,778
2,401,254
2,365,828
1,809,445
2,718,075
2,801,554
2,359,456
1,947,802
2,161,742
1,620,732
1,794,684
1,794,684
2,676,473
2,676,473
0
1,637,351
2,167,010
2,167,010
2,167,0102,167,0101,637,35102,676,4732,676,4731,794,6841,794,6841,620,7322,161,7421,947,8022,359,4562,801,5542,718,0751,809,4452,365,8282,401,2542,257,7781,832,1660841,4820928,60701,165,2290922,8010807,2120767,59201,430,4310809,2000529,0700476,1260463,9930306,9870276,599238,5330244,8360162,360199,955125,839112,80079,91972,91340,72029,19423,86838,16420,55921,15117,23632,999
       Other Current Liabilities 
236,367
220,571
325,411
142,015
184,894
147,039
249,674
245,900
484,158
391,697
604,879
560,029
808,023
904,964
0
1,542,451
0
1,081,397
1,669,773
0
1,553,386
0
2,368,053
0
2,029,591
0
3,538,347
0
2,616,885
0
4,019,723
0
3,336,470
0
4,905,762
0
3,862,203
0
4,738,113
0
4,018,537
0
5,768,571
0
1,678,458
0
6,938,403
6,916,083
2,063,189
6,971,520
7,388,762
7,241,594
7,414,213
6,971,358
8,018,917
1,683,327
1,683,327
9,470,830
9,470,830
8,789,485
8,789,485
14,175,665
14,175,665
14,175,66514,175,6658,789,4858,789,4859,470,8309,470,8301,683,3271,683,3278,018,9176,971,3587,414,2137,241,5947,388,7626,971,5202,063,1896,916,0836,938,40301,678,45805,768,57104,018,53704,738,11303,862,20304,905,76203,336,47004,019,72302,616,88503,538,34702,029,59102,368,05301,553,38601,669,7731,081,39701,542,4510904,964808,023560,029604,879391,697484,158245,900249,674147,039184,894142,015325,411220,571236,367
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,564,320
4,517,072
4,554,103
9,891,658
15,756,548
16,310,585
15,796,670
13,847,341
0
13,612,165
0
7,469,295
0
9,924,343
0
5,970,059
0
2,316,667
2,316,66705,970,05909,924,34307,469,295013,612,165013,847,34115,796,67016,310,58515,756,5489,891,6584,554,1034,517,0722,564,320000000000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
507,066
541,631
2,464,060
2,553,109
7,926,072
13,882,932
14,420,530
13,937,337
13,067,488
13,038,236
12,258,740
0
5,685,272
0
7,983,305
0
4,258,122
0
1,031,340
1,031,34004,258,12207,983,30505,685,272012,258,74013,038,23613,067,48813,937,33714,420,53013,882,9327,926,0722,553,1092,464,060541,631507,06600000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
7,475
7,702
16,392
7,587
7,882
11,629
10,581
5,985
25,747
0
64,609
0
62,539
66,916
0
90,108
0
84,955
0
96,197
0
98,941
0
119,050
0
128,501
0
141,638
0
165,828
0
225,029
0
133,986
0
241,912
0
785,488
0
2,054,997
0
2,053,012
2,000,994
1,965,586
1,873,616
1,890,055
1,859,333
1,219,041
1,361,728
1,804,830
1,936,820
1,936,820
2,025,515
2,025,515
0
0
1,285,342
1,285,342
1,285,3421,285,342002,025,5152,025,5151,936,8201,936,8201,804,8301,361,7281,219,0411,859,3331,890,0551,873,6161,965,5862,000,9942,053,01202,054,9970785,4880241,9120133,9860225,0290165,8280141,6380128,5010119,050098,941096,197084,955090,108066,91662,539064,609025,7475,98510,58111,6297,8827,58716,3927,7027,47500000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
128,658
0
0
0
164,140
0
0
0
504,979
0
0
0
716,838
0
0
0
699,363
0
0
772,459
772,459
0
0
0
0
0
0
000000772,459772,45900699,363000716,838000504,979000164,140000128,658000000000000000000000000000000000000
> Total Stockholder Equity
359,476
456,074
491,441
1,853,247
1,838,963
1,908,562
1,906,242
2,019,248
2,079,622
2,228,928
2,283,601
2,474,348
3,489,860
3,647,685
0
3,603,588
0
3,836,005
4,002,877
0
4,581,976
0
4,932,345
0
5,487,016
0
5,786,564
0
6,610,642
0
7,324,616
0
7,755,888
0
8,369,836
0
8,884,724
0
8,644,077
0
9,208,794
0
20,293,762
0
29,212,838
29,673,993
29,924,114
30,576,102
31,111,658
31,706,082
31,513,993
31,672,369
16,747,160
18,665,621
24,575,623
0
30,291,116
0
30,214,155
0
29,747,035
0
29,989,295
29,989,295029,747,035030,214,155030,291,116024,575,62318,665,62116,747,16031,672,36931,513,99331,706,08231,111,65830,576,10229,924,11429,673,99329,212,838020,293,76209,208,79408,644,07708,884,72408,369,83607,755,88807,324,61606,610,64205,786,56405,487,01604,932,34504,581,97604,002,8773,836,00503,603,58803,647,6853,489,8602,474,3482,283,6012,228,9282,079,6222,019,2481,906,2421,908,5621,838,9631,853,247491,441456,074359,476
   Common Stock
33,200
34,428
56,599
56,599
56,599
56,599
56,599
56,599
56,599
56,599
75,466
113,198
123,916
123,916
0
123,916
0
123,536
123,536
0
123,536
0
123,536
0
123,536
0
123,536
0
123,536
0
123,536
0
185,305
0
185,305
0
185,305
0
170,033
0
170,033
0
279,208
0
278,846
278,452
278,452
278,452
278,451
278,315
278,301
416,138
415,895
415,895
415,895
415,440
415,440
414,942
414,942
0
414,899
414,615
414,615
414,615414,615414,8990414,942414,942415,440415,440415,895415,895415,895416,138278,301278,315278,451278,452278,452278,452278,8460279,2080170,0330170,0330185,3050185,3050185,3050123,5360123,5360123,5360123,5360123,5360123,5360123,536123,5360123,9160123,916123,916113,19875,46656,59956,59956,59956,59956,59956,59956,59956,59934,42833,200
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000-2,065,536000-1,371,906000-1,066,307000-848,181000-685,701000-544,819000-389,491000-328,08600-249,34600000-167,56600000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,020,536
0
12,944,137
0
12,944,429
0
12,883,158
0
12,668,722
0
12,668,722
0
12,555,650
0
12,465,805
0
12,461,438
0
12,420,311
12,420,311012,461,438012,465,805012,555,650012,668,722012,668,722012,883,158012,944,429012,944,137013,020,53600000000000000000000000000000000000000000000
   Treasury Stock000000-689,3470-469,944-469,944-469,944-412,837-412,837-412,837-412,837-443,432-427,448-415,787-457,2880-188,819000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-385,468
0
-178,954
0
-587,269
0
-513,774
0
-462,850
0
-394,591
30,741,082
-350,945
31,840,604
-299,731
31,669,068
16,801,209
18,719,670
-9,364,169
-9,227,928
-9,227,928
-9,854,995
-9,854,995
0
-860,860
-9,882,505
-9,882,505
-9,882,505-9,882,505-860,8600-9,854,995-9,854,995-9,227,928-9,227,928-9,364,16918,719,67016,801,20931,669,068-299,73131,840,604-350,94530,741,082-394,5910-462,8500-513,7740-587,2690-178,9540-385,468000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in HKD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue28,780,412
Cost of Revenue-5,795,510
Gross Profit22,984,90222,984,902
 
Operating Income (+$)
Gross Profit22,984,902
Operating Expense-22,744,113
Operating Income6,370,638240,789
 
Operating Expense (+$)
Research Development-
Selling General Administrative12,564,007
Selling And Marketing Expenses-
Operating Expense22,744,11312,564,007
 
Net Interest Income (+$)
Interest Income592,034
Interest Expense-172,512
Other Finance Cost-657,139
Net Interest Income-237,617
 
Pretax Income (+$)
Operating Income6,370,638
Net Interest Income-237,617
Other Non-Operating Income Expenses-
Income Before Tax (EBT)5,778,6046,370,638
EBIT - interestExpense = -172,512
2,543,570
2,716,082
Interest Expense172,512
Earnings Before Interest and Taxes (EBIT)-5,951,116
Earnings Before Interest and Taxes (EBITDA)7,264,646
 
After tax Income (+$)
Income Before Tax5,778,604
Tax Provision-775,986
Net Income From Continuing Ops5,002,6185,002,618
Net Income2,543,570
Net Income Applicable To Common Shares2,543,570
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-237,617
 

Technical Analysis of Sino Biopharmaceutical Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sino Biopharmaceutical Ltd. The general trend of Sino Biopharmaceutical Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sino Biopharmaceutical Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sino Biopharmaceutical Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2.89 < 3.44 < 3.46.

The bearish price targets are: 2.29.

Tweet this
Sino Biopharmaceutical Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sino Biopharmaceutical Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sino Biopharmaceutical Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sino Biopharmaceutical Ltd. The current macd is -0.05498273.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sino Biopharmaceutical Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Sino Biopharmaceutical Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Sino Biopharmaceutical Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Sino Biopharmaceutical Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSino Biopharmaceutical Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sino Biopharmaceutical Ltd. The current adx is 20.78.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Sino Biopharmaceutical Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Sino Biopharmaceutical Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sino Biopharmaceutical Ltd. The current sar is 2.44871508.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Sino Biopharmaceutical Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sino Biopharmaceutical Ltd. The current rsi is 55.02. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Sino Biopharmaceutical Ltd Daily Relative Strength Index (RSI) ChartSino Biopharmaceutical Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sino Biopharmaceutical Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sino Biopharmaceutical Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Sino Biopharmaceutical Ltd Daily Stochastic Oscillator ChartSino Biopharmaceutical Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sino Biopharmaceutical Ltd. The current cci is 62.16.

Sino Biopharmaceutical Ltd Daily Commodity Channel Index (CCI) ChartSino Biopharmaceutical Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sino Biopharmaceutical Ltd. The current cmo is 22.13.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Sino Biopharmaceutical Ltd Daily Chande Momentum Oscillator (CMO) ChartSino Biopharmaceutical Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sino Biopharmaceutical Ltd. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Sino Biopharmaceutical Ltd Daily Williams %R ChartSino Biopharmaceutical Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sino Biopharmaceutical Ltd.

Sino Biopharmaceutical Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sino Biopharmaceutical Ltd. The current atr is 0.12101056.

Sino Biopharmaceutical Ltd Daily Average True Range (ATR) ChartSino Biopharmaceutical Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sino Biopharmaceutical Ltd. The current obv is -349,526,955.

Sino Biopharmaceutical Ltd Daily On-Balance Volume (OBV) ChartSino Biopharmaceutical Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sino Biopharmaceutical Ltd. The current mfi is 44.97.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Sino Biopharmaceutical Ltd Daily Money Flow Index (MFI) ChartSino Biopharmaceutical Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sino Biopharmaceutical Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Sino Biopharmaceutical Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sino Biopharmaceutical Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.021
Ma 20Greater thanMa 502.697
Ma 50Greater thanMa 1002.939
Ma 100Greater thanMa 2003.045
OpenGreater thanClose2.720
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sino Biopharmaceutical Ltd with someone you think should read this too:
  • Are you bullish or bearish on Sino Biopharmaceutical Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sino Biopharmaceutical Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sino Biopharmaceutical Ltd

I send you an email if I find something interesting about Sino Biopharmaceutical Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Sino Biopharmaceutical Ltd.

Receive notifications about Sino Biopharmaceutical Ltd in your mailbox!